UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington
D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE
OF REPORT (DATE OF EARLIEST EVENT REPORTED): APRIL 28,
2009
Commission
File Number: 0-24260
AMEDISYS,
INC.
(Exact
Name of Registrant as specified in its Charter)
|
Delaware
|
11-3131700
|
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
5959
S. Sherwood Forest Blvd., Baton Rouge, LA 70816
(Address
of principal executive offices, including zip code)
(225)
292-2031 or (800) 467-2662
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Information
to be included in the report
Section 2
— Financial Information
Item
2.02. Results of Operations and Financial
Condition
On
April 28, 2009, Amedisys, Inc. (“we,” “us,” “our” or the “Company”) issued
a press release announcing its earnings for the three-month period ended
March 31, 2009. A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.
The
information presented in Item 2.02 of this Current Report on Form 8-K and
Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the liabilities of that section, unless
we specifically state that the information is to be considered “filed” under the
Exchange Act or specifically incorporate it by reference in any filing under the
Securities Exchange Act of 1933, as amended, or the Exchange Act.
Section
7 – Regulation FD
Item
7.01. Regulation FD Disclosure
Item
2.02 of this Current Report on Form 8-K is incorporated herein by
reference.
The
information presented in Item 7.01 of this Current Report on Form 8-K shall
not be deemed “filed” for purposes of Section 18 of the Exchange Act, or
otherwise subject to the liabilities of that section, unless we specifically
state that the information is to be considered “filed” under the Exchange Act or
specifically incorporate it by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act.
Section
9 – Financial Statements and Exhibits
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits.
2
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
AMEDISYS,
INC.
(Registrant)
|
||
|
By:
|
/s/ Dale
E. Redman
|
|
|
Dale
E. Redman
|
||
|
Chief Financial Officer and Duly Authorized Officer
|
||
DATE:
April 28, 2009
3
Exhibit
Index
|
Exhibit No.
|
Description
|
|
|
99.1
|
4